These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32705916)

  • 21. The effects of isotretinoin therapy on the biliary system.
    Saylam Kurtipek G; Ulutas Demirbas G; Demirbas A; Sarı N; Zekey E; Tuncez Akyurek F; Güngör G
    Dermatol Ther; 2020 Jan; 33(1):e13177. PubMed ID: 31769896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of sequential effect of isotretinoin on the haematological parameters in patients with acne vulgaris.
    Gencoglan G; Inanir I; Miskioglu M; Gunduz K
    Cutan Ocul Toxicol; 2018 Jun; 37(2):139-142. PubMed ID: 28743196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin.
    El-Hamd MA; El Taieb MA; Ibrahim HM; Aly SS
    J Cosmet Dermatol; 2019 Feb; 18(1):16-20. PubMed ID: 29460332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eruptive milia during isotretinoin therapy.
    Farmer W; Cheng K; Marathe K
    Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Laboratory Follow-up in Acne Patients Treated With Isotretinoin.
    Özaslan M; Peker D
    Cutis; 2023 Jul; 112(1):38-43. PubMed ID: 37611311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hematological parameters in patients using systemic isotretinoin with diagnosis of acne vulgaris.
    Demirci Saadet E; Sahin U
    J Cosmet Dermatol; 2023 Mar; 22(3):1077-1082. PubMed ID: 36437707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters.
    Murshidi R; Bani Hamad S; Al Refaei A; Shewaikani N; Shaf'ei M; Alshoubaki SN; Haddad TA; Khasawneh T; Fkheideh T; Abdallat M
    J Dermatolog Treat; 2024 Dec; 35(1):2301435. PubMed ID: 38186323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory Abnormalities in Acne Patients Treated With Oral Isotretinoin: A Retrospective Epidemiological Study.
    Alajaji A; Alrawaf FA; Alosayli SI; Alqifari HN; Alhabdan BM; Alnasser MA
    Cureus; 2021 Oct; 13(10):e19031. PubMed ID: 34853752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardized laboratory monitoring with use of isotretinoin in acne.
    Hansen TJ; Lucking S; Miller JJ; Kirby JS; Thiboutot DM; Zaenglein AL
    J Am Acad Dermatol; 2016 Aug; 75(2):323-8. PubMed ID: 27189824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse.
    Cakir GA; Erdogan FG; Gurler A
    Int J Dermatol; 2013 Mar; 52(3):371-6. PubMed ID: 22998438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
    Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
    Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of thyroid function tests of acne vulgaris patients treated with systemic isotretinoin.
    Yıldırım N; Doğan S; Atakan N
    J Dermatolog Treat; 2017 Mar; 28(2):141-144. PubMed ID: 27425198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creatine phosphokinase values during isotretinoin treatment for acne.
    Kaymak Y
    Int J Dermatol; 2008 Apr; 47(4):398-401. PubMed ID: 18377609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
    Kutlu Ö
    Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse effects of isotretinoin: A large, retrospective review.
    Brzezinski P; Borowska K; Chiriac A; Smigielski J
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28295859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore.
    Shahidullah M; Tham SN; Goh CL
    Int J Dermatol; 1994 Jan; 33(1):60-3. PubMed ID: 8112947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose Vitamin "A" Tablets-treatment of Acne Vulgaris.
    Kotori MG
    Med Arch; 2015 Feb; 69(1):28-30. PubMed ID: 25870473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.